EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibodies Against SARS-CoV-2 Do Not Cross-React with Endemic Coronaviruses in a Pediatric Population: Data from a Bangladesh Cohort

Ana Citlali Márquez iD, Guadalein Tanunliong iD, Mamun Kabir iD, Masud Alam, Biplob Hossain, Humaira Rashid, Agatha N Jassem, Inna Sekirov, Rashidul Haque iD, Muhammad Morshed

Viruses · 2025

DOI: 10.3390/v17020161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Ana Citlali Márquez und 9 weiteren Autor:innen. Beteiligte Einrichtung: BCCDC Public Health Laboratory, Vancouver, BC V5Z 4R4, Canada. Hauptthemen laut MEDLINE: Antibodies, Viral, SARS-CoV-2, COVID-19, Coronavirus. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a limited understanding of the immunological differences between children and adults that protect children from developing severe coronavirus disease 2019 (COVID-19) following SARS-CoV-2 infection. Previous infection with endemic human coronaviruses (HCoVs) has been suggested as a factor. In this study, we used 100 paired residual samples collected before and during the COVID-19 pandemic from children in Bangladesh. We compared the changes in their sero-status (no COVID-19 vs. COVID-19) and quantified antibody levels to HCoVs. We found that although 45% of the children seroconverted for IgG antibodies against SARS-CoV-2, there was no correlation between evidence of previous infection with HCoVs and the magnitude of SARS-CoV-2 antibody responses post-infection. Moreover, no differences in the anti-HCoV antibody levels were found pre- and post-SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralSARS-CoV-2COVID-19CoronavirusHumansBangladeshChildImmunoglobulin GMaleChild, PreschoolFemaleCross ReactionsAdolescentInfantCohort Studies

Stichwörter der Autor:innen

COVID-19HCoVsSARS-CoV-2

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • BCCDC Public Health Laboratory, Vancouver, BC V5Z 4R4, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • International Centre for Diarrhoeal Disease Research, Dhaka 1212, Bangladesh.

ORCID-Profile: Ana Citlali Márquez, Guadalein Tanunliong, Mamun Kabir, Rashidul Haque

Förderung

  • NIAID NIH HHS
  • National Institute of Health, USA

Zitieren

APA

Márquez, A. C., Tanunliong, G., Kabir, M., Alam, M., Hossain, B., Rashid, H., Jassem, A. N., Sekirov, I., Haque, R., & Morshed, M. (2025). Antibodies Against SARS-CoV-2 Do Not Cross-React with Endemic Coronaviruses in a Pediatric Population: Data from a Bangladesh Cohort. Viruses. https://doi.org/10.3390/v17020161

Vancouver

Márquez AC, Tanunliong G, Kabir M, Alam M, Hossain B, Rashid H, et al. Antibodies Against SARS-CoV-2 Do Not Cross-React with Endemic Coronaviruses in a Pediatric Population: Data from a Bangladesh Cohort. Viruses. 2025. doi:10.3390/v17020161

BibTeX
@article{Mrquez2025,
  author = {Márquez, Ana Citlali and Tanunliong, Guadalein and Kabir, Mamun and Alam, Masud and Hossain, Biplob and Rashid, Humaira and Jassem, Agatha N and Sekirov, Inna and Haque, Rashidul and Morshed, Muhammad},
  title = {Antibodies Against SARS-CoV-2 Do Not Cross-React with Endemic Coronaviruses in a Pediatric Population: Data from a Bangladesh Cohort},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020161}
}
Kostenlos starten →